Biopoint India Profile
Key Indicators
- Authorised Capital ₹ 7.00 Cr
- Paid Up Capital ₹ 6.87 Cr
- Company Age 4 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 25.05 Cr
- Revenue Growth %
- Profit Growth -95.78%
- Ebitda -94.73%
- Net Worth -6.77%
- Total Assets 91.89%
About Biopoint India
Biopoint India Private Limited (BIPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 04 August 2020 (Four years and six months 20 days old ). Its registered office is in Bangalore, Karnataka, India.
The Company is engaged in the Environment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.00 Cr and a paid-up capital of Rs 6.87 Cr.
The company currently has active open charges totaling ₹25.05 Cr.
Aniketan Paandomatti and Nellihankalu Amulya serve as directors at the Company.
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24290KA2020PTC136838
- Company No.
136838
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Aug 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Biopoint India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aniketan Paandomatti  | Director | 04-Aug-2020 | Current |
| Nellihankalu Amulya | Director | 04-Aug-2020 | Current |
Financial Performance of Biopoint India.
Biopoint India Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 95.78% decrease in profit. The company's net worth dipped by a decrease of 6.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biopoint India?
In 2022, Biopoint India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹25.05 Cr
₹0
Charges Breakdown by Lending Institutions
- Canara Bank : 21.80 Cr
- Others : 3.25 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Mar 2024 | Others | ₹3.25 M | Open |
| 13 Feb 2024 | Others | ₹2.75 M | Open |
| 31 Oct 2023 | Others | ₹7.00 M | Open |
| 31 Aug 2023 | Others | ₹6.50 M | Open |
| 10 Jul 2023 | Others | ₹7.00 M | Open |
How Many Employees Work at Biopoint India?
Biopoint India has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biopoint India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biopoint India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
